Michael Becker to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Michael Becker has written about Drug Resistance, Neoplasm.
Connection Strength
0.182
-
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP. Clin Cancer Res. 2018 05 15; 24(10):2452-2463.
Score: 0.105
-
A phase I study of decitabine and rapamycin in relapsed/refractory AML. Leuk Res. 2013 Dec; 37(12):1622-7.
Score: 0.077